Literature DB >> 2433865

Differential effects of 5-fluorouracil on human skin melanocytes and malignant melanoma cells in vitro.

T Tsuji, M A Karasek.   

Abstract

We have observed differential effects of the cytotoxicity of 5-fluorouracil (5-FU) on human skin melanocytes and malignant melanoma cells in vitro. In the absence of 5-FU the melanoma cells multiplied much more rapidly than the melanocytes. With a 7-day exposure of 5-FU (1.92 X 10(-5) to 3.84 X 10(-4) M) all the melanoma cells died by 5 W, while even two times longer exposure (a 14-day exposure) of 5-FU the melanocytes survived till 6 W and increased at the lower concentration. In the presence of 5-FU there was a different compensatory increase in [3H] thymidine incorporation between the two cell types. That is, compared with the large increase observed in the incorporation by the melanoma cells, a small increase in the incorporation by the melanocytes was observed. The reason for these differential effects of 5-FU may be the difference in the cell cycle and the post-injury cell renewal of the two cell types.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433865

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

1.  Topical Delivery of 5-Fluorouracil from Pheroid™ Formulations and the In Vitro Efficacy Against Human Melanoma.

Authors:  Tawona N Chinembiri; Minja Gerber; Lissinda du Plessis; Jan du Preez; Jeanetta du Plessis
Journal:  AAPS PharmSciTech       Date:  2015-05-09       Impact factor: 3.246

2.  Efficacy of Topical 5% 5-Fluorouracil with Needling versus 5% 5-Fluorouracil Alone in Stable Vitiligo: A Randomized Controlled Study.

Authors:  Fatima T Zahra; Mohammad Adil; Syed S Amin; Mohd Mohtashim; Roopal Bansal; Hania Q Khan
Journal:  J Cutan Aesthet Surg       Date:  2020 Jul-Sep

3.  Possible mechanisms by which topical 5-Fluorouracil and dermabrasion could induce pigment spread in vitiligo skin: an experimental study.

Authors:  Y Gauthier; T Anbar; S Lepreux; M Cario-André; L Benzekri
Journal:  ISRN Dermatol       Date:  2013-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.